https://www.businesswire.com/news/home/20260830241804/en/AM-Best-to-Sponsor-and-Exhibit-at-2026-East-Asian-Insurance-Congress 2026-08-30T23:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830564142/en/Faraday-Future-Founder-and-Global-CEO-YT-Jia-Shares-Weekly-Investor-Update-New-Robot-Deliveries-and-Updates-from-the-Middle-East-Recap-on-FF-EAI-Robotics-Built-in-USA-Business-Partner-Conference-Held-Last-Week-RoboShare-Officially-Launched 2026-08-30T23:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830994316/en/LHX-Investors-Have-Opportunity-to-Join-L3Harris-Technologies-Inc.-Fraud-Investigation-with-SBS-Law 2026-08-30T20:49:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830525751/en/CLMT-Investors-Have-Opportunity-to-Join-Calumet-Inc.-Fraud-Investigation-with-SBS-Law 2026-08-30T20:46:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829969056/pt 2026-08-30T18:27:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830433829/en/Sygnia-Reveals-New-Activity-by-China-Nexus-Threat-Actor-Fire-Ant-Targeting-Trusted-Infrastructure 2026-08-30T17:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830813912/en/Arrowhead-Pharmaceuticals-Presents-Phase-3-SHASTA-3-and-SHASTA-4-Data-Demonstrating-Plozasiran-Reduced-Acute-Pancreatitis-Events-in-Patients-with-Severe-Hypertriglyceridemia 2026-08-30T15:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260828306016/en/L3Harris-Celebrates-Successful-Launch-of-NASAs-Nancy-Grace-Roman-Space-Telescope 2026-08-30T13:30:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830385370/en/Angel-Armor-Launches-the-RISE-Plate-Carrier-Expanding-Coverage-Without-Sacrificing-Mobility 2026-08-30T13:00:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829551848/en/Alnylam-Presents-New-Data-at-ESC-Congress-2026-Reinforcing-Strength-in-RNAi-Powered-TTR-Silencing-Across-ATTR-CM-Patient-Populations-and-Treatment-Settings 2026-08-30T12:23:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260830902078/en/Bayer-Announces-Phase-III-REVEAL-Study-with-Investigational-PET-Radiotracer-Iodine-124-Evuzamitide-Presented-as-Late-Breaker-at-ESC-2026 2026-08-30T11:45:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829143450/zh-CN 2026-08-30T08:17:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829635557/zh-HK 2026-08-30T08:17:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829198382/es 2026-08-30T08:17:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829765396/ja 2026-08-30T03:29:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829549865/de 2026-08-30T03:29:00.000Z weekly 0.5 https://www.businesswire.com/news/home/20260829058247/en/Stockholder-Alert-Robbins-LLP-Informs-Investors-of-the-Innventure-Inc.-Class-Action 2026-08-30T00:10:00.000Z weekly 0.5